These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 17084841

  • 1. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
    Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV.
    Exp Cell Res; 2007 Jan 01; 313(1):168-78. PubMed ID: 17084841
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS, Suh KS, Sul D, Kim BJ, Lee SK, Jung WW.
    Int J Mol Med; 2012 Feb 01; 29(2):169-77. PubMed ID: 22038020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 01; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY, Yoon KH, Choi MK, Lee MS, Oh J.
    Bone; 2015 Oct 01; 79():242-51. PubMed ID: 26103094
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
    Kim WS, Kim HJ, Lee ZH, Lee Y, Kim HH.
    Exp Cell Res; 2013 Feb 15; 319(4):436-46. PubMed ID: 23246654
    [Abstract] [Full Text] [Related]

  • 11. Isoproterenol Increases RANKL Expression in a ATF4/NFATc1-Dependent Manner in Mouse Osteoblastic Cells.
    Baek K, Park HJ, Baek JH, Kim HR.
    Int J Mol Sci; 2017 Oct 20; 18(10):. PubMed ID: 29053621
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
    Odkhuu E, Koide N, Haque A, Tsolmongyn B, Naiki Y, Hashimoto S, Komatsu T, Yoshida T, Yokochi T.
    Immunol Lett; 2012 Feb 29; 142(1-2):34-40. PubMed ID: 22193059
    [Abstract] [Full Text] [Related]

  • 13. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation.
    Park K, Ju WC, Yeo JH, Kim JY, Seo HS, Uchida Y, Cho Y.
    Int J Mol Med; 2014 Jan 29; 33(1):178-84. PubMed ID: 24248634
    [Abstract] [Full Text] [Related]

  • 14. Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase.
    Choe JY, Park KY, Kim SK.
    Mediators Inflamm; 2015 Jan 29; 2015():597512. PubMed ID: 26347587
    [Abstract] [Full Text] [Related]

  • 15. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
    Ko SY.
    Arch Oral Biol; 2012 Dec 29; 57(12):1623-32. PubMed ID: 22795564
    [Abstract] [Full Text] [Related]

  • 16. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 17. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.
    Yu M, Moreno JL, Stains JP, Keegan AD.
    J Biol Chem; 2009 Nov 20; 284(47):32968-79. PubMed ID: 19801646
    [Abstract] [Full Text] [Related]

  • 18. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.
    Zeng XZ, He LG, Wang S, Wang K, Zhang YY, Tao L, Li XJ, Liu SW.
    Acta Pharmacol Sin; 2016 Feb 20; 37(2):255-63. PubMed ID: 26592521
    [Abstract] [Full Text] [Related]

  • 19. NIP45 negatively regulates RANK ligand induced osteoclast differentiation.
    Shanmugarajan S, Haycraft CJ, Reddy SV, Ries WL.
    J Cell Biochem; 2012 Apr 20; 113(4):1274-81. PubMed ID: 22105856
    [Abstract] [Full Text] [Related]

  • 20. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.
    J Bone Miner Res; 2011 Mar 20; 26(3):644-56. PubMed ID: 20814972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.